BCOP Updates 2025: The Beans are Making a Scene: Updates in Renal Cell Carcinoma

Type: Individual•Format: On-demand

Prepare to "spill the beans" on renal cell carcinoma (RCC) as we delve into the latest advancements in care. We'll examine the distinctions between clear cell and non-clear cell types while exploring the evolving treatment landscape in both adjuvant and advanced settings, emphasizing recent clinical trial outcomes and personalized strategies. We'll also investigate future directions in biomarker development and emerging therapies. Join us to discover the most "un-bean-lievable" updates in RCC.

BCOP Updates 2025: The Beans are Making a Scene: Updates in Renal Cell Carcinoma

Authors: Kelly M. Brunk, PharmD, BCOP, and Timothy J. Schieber, PharmD, MBA

Learning Objectives

  1. Describe the role of adjuvant immunotherapy in clear cell renal cell carcinoma (RCC)
  2. Discuss first-line treatment strategies for advanced clear cell RCC
  3. Explain subsequent-line treatment of advanced clear cell RCC, addressing the controversy of reusing immune checkpoint inhibitors
  4. Summarize treatment options for non-clear cell RCC

Get it now!

Knowledge Course for Pharmacists

Technology requirements: HOPA Learn requires a modern web browser (Internet Explorer 7+, Mozilla Firefox, Apple Safari, Google Chrome) and the ability to listen to audio with the content.

acpe-bps-logos

HOPA is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. In order to claim BCOP credit, you must pass the BCOP Post-Test with a 75% or higher.

All CE hours will be transmitted to the CPE Monitor and BPS within 1-2 weeks of course completion.